An Intention to Float has been published by Siemens as it prepares for an initial public offering of its medtech division, Siemens Healthineers, at the DAX stock exchange in Germany, which could take place as early as March. Siemens noted that it will retain a majority stake in the unit and will eventually provide support for the division.
Omar Ishrak, chairman and CEO of Medtronic, discusses the company's venture into outcomes-based contracts, which he said help companies ensure fair payment when the value created with their products is realized. Ishrak sees chronic-disease management as a growth area for outcomes-based deals, and hopes that all the company's revenue will be tied to outcomes-based measurements.
An initial public offering of 3.5 million shares of common stock has been closed by Motus GI, raising $17.5 million in gross proceeds. The company, which granted a 30-day option for the underwriters to buy 525,000 additional shares, intends to use the net proceeds as working capital, to commercialize its Pure-Vu colonoscopy device and to support research and development efforts.
A planned initial coin offering could bring in around $18.5 million for Cyprus-based NnBU, which is developing a blockchain-based medical device for providing healthy outcomes for caesarean-section newborns through torso massage and simulation of the positive stresses of natural childbirth. The company, which earned a patent for the neonatal birth unit after completion of the product's conceptual design, intends to use the proceeds to support product development and commercialization.
A business center will be built by California-based Quidel in Ireland to better position itself in providing services to customers in the international market -- a move that will create 75 jobs. The company hopes to hire people for finance, customer service, technical support, human resources, sales, marketing, legal and information technology roles in the facility over the next five years.
Hologic saw a $701.1 million year-over-year revenue growth during the fiscal first quarter ending Dec. 30 of last year, driven by its molecular diagnostics, breast health and international businesses. Chairman, President and CEO Steve MacMillan said, "[T]ax reform is helping us increase our earnings guidance for the year, while simultaneously re-investing in the business to drive future growth."
University of California, San Diego, engineers have created a smartphone case that, when paired with an app, can make it easier for people with diabetes to track and record blood glucose levels on the go. "Integrating blood glucose sensing into a smartphone would eliminate the need for patients to carry a separate device," said Patrick Mercier, professor of electrical and computer engineering at UC San Diego. "An added benefit is the ability to autonomously store, process and send blood glucose readings from the phone to a care provider or cloud service," he said. GlucPhone is a portable glucose-sensing system created by Mercier and nanoengineering professor Joseph Wang. The device has two parts: The first is a slim, 3D-printed case with a permanent, reusable sensor in the corner. The second part contains small, one-time-use, enzyme-packed pellets and attaches to the sensor with a magnet. The pellets are encased in a 3D-printed stylus attached to the side of the case.
An international team of researchers created a power source for implantable medical devices using the electric eel's shock-producing biochemical system as inspiration. The device, which consists of stacks of hydrogels that have different salinity levels and are serially wired using 3D-printing technology, can release up to 110 volts of electrical current when folded, the scientists reported in the journal Nature.
A study by Google and Alphabet unit Verily Life Sciences published in the journal Nature Biomedical Engineering found that high blood pressure or the risk of stroke or heart attack may be predicted by analyzing retinal image scans using Google's intricate pattern-recognizing algorithms, or neural networks. However, the technique, which was performed on more than 280,000 patients across the UK and the US, had an accuracy rate of 70% and did not perform better than existing medical approaches.
Dai Nippon Printing and a team of University of Tokyo researchers developed an integrated biomedical sensor system, called "skin electronics," which allows the moving electrocardiogram waveform recorded by a lightweight sensor to be shown on a wearable elastic skin display. The sensor system, which Dai Nippon Printing expects to market within the next three years, comes with a wireless communication module, enabling the transmission of biometric data to the cloud for storage or a smartphone for viewing.
More than 300 standards will be revised by the China Food and Drug Administration under a two-year plan to align the country's medical devices and in vitro diagnostics with international standards and as part of existing reforms that include better quality system management and oversight and more stringent device standards. The agency intends to promote innovation and determine priority areas for the development of devices to resolve unmet needs.
Feb 26-27, 2018 | Irvine, Calif. This two-day workshop provides attendees the unique opportunity to better understand the FDA perspective on 510(k) submissions, from processes to approval to modifications. Throughout the workshop you'll obtain actionable insights and strategies for assembling and streamlining an effective 510(k) submission. Learn more.